SCHEMBL3375924

SCHEMBL3375924

O=C(NC[C@H](O)CNc1ccc(N2CCOCC2=O)cc1)C1=CC(Cl)=CCC1=S

nearest known ligand 0.44

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
F10 P00742 18/20 0.44
PTGS2 P35354 2/20 0.40
ABCB11 O95342 1/20 0.40
F2 P00734 1/20 0.40
ST14 Q9Y5Y6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3156175 1.00 F10 (0.44) F10PTGS2ABCB11F2ST14
SCHEMBL3156588 0.89 F10 (0.44) F10
SCHEMBL3148052 0.88 F10 (0.40) F10
SCHEMBL3155591 0.87 KLKB1 (0.34) F10
SCHEMBL3146428 0.87 F10 (0.45) F10
SCHEMBL3146160 0.87 F10 (0.47) F10
SCHEMBL5738609 0.87 RAB9A (0.43) F10
SCHEMBL3151687 0.86 F10 (0.37) F10ABCB11F2ST14
SCHEMBL3151799 0.85 F10 (0.50) F10
SCHEMBL3160134 0.85 F10 (0.36) F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1874764-B1 IMINO-OXAZOLIDINES AND USE THEREOF AS ANTICOAGULANTS BAYER SCHERING PHARMA AG (DE) 2010-11-10 EP disclosed
EP-1874764-A2 IMINO-OXAZOLIDINES AND USE THEREOF AS ANTICOAGULANTS Bayer HealthCare AG (DE) 2008-01-09 EP disclosed
WO-2006111285-A2 IMINO-OXAZOLIDINES AND USE THEREOF AS ANTICOAGULANTS BAYER HEALTHCARE AG (DE) 2006-10-26 WO disclosed
EP-1626969-A1 HETEROCYCLIC COMPOUNDS Bayer HealthCare AG (DE) 2006-02-22 EP disclosed
WO-2004101557-A1 HETEROCYCLIC COMPOUNDS BAYER HEALTHCARE AG (DE) 2004-11-25 WO disclosed